You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Low‐dose intermittent urokinase therapy in chronic symptomatic end‐stage arterial disease – clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease

Price: EUR 27.50